Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
5 drugs in development
By Therapeutic Area
top 3
R&D Momentum
59/100
Pipeline Velocity
36/100
Trial Completion Rate
86/100
Pipeline Concentration
39/100
Pipeline Freshness
55/100
Strategic Signals
Activity
Last 14 days
The Study of Improving Antipsychotic-induced Appetite by Deep Transcranial Magnetic Stimulation: The Effects of Improving Antipsychotic-induced Appetite by Single Session dTMS After Food Cue-induced Craving, A Randomized, Crossover and Sham-Controlled Trail
The Effects of Improving Antipsychotic-induced Weight Gain by Accelerated dTMS After Food Cue-induced Craving, A Double-Blind, Randomized, Sham-Controlled Clinical Trial.
Study of Propranolol Hydrochloride in Combination With Adebrelimab and Platinum-Based Chemotherapy in Patients With Small Cell Lung Cancer (BRIO-SCLC)
A Prospective, Multicenter, Open-Label Study of Propranolol Hydrochloride in Combination With Toripalimab and Platinum-Based Chemotherapy as Perioperative Treatment for Resectable Non-Small Cell Lung Cancer
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)